Axcella Health Inc - ESG Rating & Company Profile powered by AI
This webpage displays a free E,S&G assessment covering Axcella Health Inc. Check the bottom of this page for potential risks for Axcella Health Inc based on industry, location and size. If you work at Axcella Health Inc and you would like to licence your Sustainability aseessment, please contact us.
Axcella Health Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.7, social score of 3.2 and governance score of 4.0.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1234 | Quanterix Corp | 3.4 | Medium |
| 1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
| 1253 | Axcella Health Inc | 3.3 | Medium |
| 1253 | Calithera Biosciences Inc | 3.3 | Medium |
| 1253 | Cara Therapeutics Inc | 3.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Axcella Health Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Axcella Health Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Axcella Health Inc report the average age of the workforce?
Sign up for free to unlockDoes Axcella Health Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Axcella Health Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Axcella Health Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Axcella Health Inc offer flexible work?
Sign up for free to unlockDoes Axcella Health Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Axcella Health Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Axcella Health Inc conduct supply chain audits?
Sign up for free to unlockDoes Axcella Health Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Axcella Health Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Axcella Health Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Axcella Health Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Axcella Health Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Axcella Health Inc disclose water use targets?
Sign up for free to unlockDoes Axcella Health Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Axcella Health Inc have a product recall in the last two years?
Sign up for free to unlockDoes Axcella Health Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Axcella Health Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Axcella Health Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Axcella Health Inc disclose parental leave metrics?
Sign up for free to unlockDoes Axcella Health Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Axcella Health Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Axcella Health Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Axcella Health Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Axcella Health Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Axcella Health Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Axcella Health Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Axcella Health Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Axcella Health Inc disclose its waste policy?
Sign up for free to unlockDoes Axcella Health Inc report according to TCFD requirements?
Sign up for free to unlockDoes Axcella Health Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Axcella Health Inc disclose energy use targets?
Sign up for free to unlockDoes Axcella Health Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Axcella Health Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Axcella Health Inc
These potential risks are based on the size, segment and geographies of the company.
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.